Navigation Links
Aethlon Medical Note: Fiscal Year Revenue Guidance
Date:5/3/2012

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

On May 19th of last year, we introduced and began marketing the Aethlon ADAPT™ system, a technology platform that converges the capabilities of plasma membrane technology and affinity drug mechanisms.  Our Aethlon ADAPT™ system provides a foundation to create a pipeline of device-based therapies that selectively target disease-enhancing particles from the entire circulatory system.  On October 3rd, 2011, we disclosed our first success in marketing the Aethlon ADAPT™ system, a $6.8 million multi-year contract from the Defense Advanced Projects Agency (DARPA) that has since transitioned us from a development-stage to revenue stage organization.  Under this contract, our tasks include the development of a dialysis-like device to prevent sepsis, a fatal bloodstream infection that is often the cause of death in combat-injured soldiers.  As a courtesy to shareholders and other interested parties, the purpose of this note is to provide revenue guidance for our March 31, 2012 fiscal year end.  As a result of achieving five contract milestones between October 1, 2011 and March 31, 2012, we expect to recognize approximately $1,350,000 in contract revenue.  We also recorded our first sale of research diagnostic tools during the fiscal year, which will have a minimal effect on revenue reporting. 

About Aethlon Medical

The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
4. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
5. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
6. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
7. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
8. Aethlon Medical Releases Shareholder Letter
9. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
10. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
11. Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015   CSL Behring ... a Marketing Authorization Application (MAA) for the company,s ... IX with recombinant albumin (rIX-FP) for the prophylaxis ... Hemophilia B. Upon Swissmedic approval, rIX-FP will provide ... with dosing intervals up to 14 days. ...
(Date:7/28/2015)... July 28, 2015 Baebies, Inc. today announced ... $13 million. The oversubscribed round of financing included key ... Duke endowment), Cunning Capital, Triad, LLC, the Duke Angel ... Center. Many of Advanced Liquid Logic,s (ALL) former investors ... invested. "Rex is pleased to support ...
(Date:7/28/2015)... Fla. , July 28, 2015 ... Spectralink, the global leader in purpose-built wireless communications, ... (Bay Area Regional), a 104-bed acute-care facility in ... to implement the Voalte One™ solution on Spectralink ... "Since Spectralink named Voalte a member of ...
Breaking Medicine Technology:Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3
... 2010 ViroPharma Incorporated (Nasdaq: VPHM ) ... Cinryze ® (C1 esterase inhibitor [human]) at the ... (WAO), December 5 through 8 in Dubai, UAE.   ... these data, which were first presented at the November ...
... Healthcare, a world-leading developer, manufacturer and marketer of innovative ... that in connection with a refinancing of its debt ... in combination with new senior secured credit facilities, it ... Senior Notes. The offering of the new notes will ...
Cached Medicine Technology:Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 2Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 3Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 4Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 5Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 6Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 7Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 8Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO) 9ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering 2ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering 3
(Date:7/28/2015)... ... ... Dr. Edward Buckingham and Buckingham Center for Facial Plastic Surgery, ... Coming to Austin from Philadelphia, Dr. Roy will be completing his Fellowship in facial ... annually by the American Academy of Facial Plastic and Reconstructive Surgery. , Since ...
(Date:7/28/2015)... ... 28, 2015 , ... DuPont leaders today joined public and ... more about the impact of U.S. collaborations with local partners under the U.S. ... development as an engine of broad-based economic growth in the region. , ...
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a leading global ... that enable the Internet of Things (IoT), announced its new medical panel PC, ... exceptional computing power and multitasking capabilities. The MLC 4-21 is completely fanless, and ...
(Date:7/28/2015)... ... 2015 , ... Dr. Aziz Ahmad recently gave a talk on the current ... 1 p.m. Tuesday, June 23, at the Gulf Coast Regional Medical Center Large HR ... in colorectal surgery and has more than 35 years of experience in the surgical ...
(Date:7/28/2015)... ... ... Egg freezing is becoming an increasingly popular option for family ... Dr. Michael Kettel explained in an article from the San Diego Union-Tribune ... generations who had to make choices between their fertility and their career or personal ...
Breaking Medicine News(10 mins):Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3
... Buyout augments existing business in Philadelphia, New York ... in Tucson, Melbourne, Fla., and San Antonio, ... provider of care and care management services for,frail ... reached agreement,to acquire Care Level Management of Woodland ...
... million of required financing now in place ... - Bioniche Life Sciences,Inc. (TSX: BNC), a ... it has secured an amendment,to a pre-existing ... Office of Industry Canada that will support ...
... CHICAGO, June 25 In response to news reports ... is allegedly being treated,for medication use related to migraine, ... Migraine is not a daily headache and the use ... basis is not recommended., Pain killers are not ...
... KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- The Board ... "Company"; stock code:,8180.HK) is pleased to announce ... in entering China,s hospital management market through ... Limited and,Daopei Hospitals Group, the largest private ...
... stocked in nationwide pharmacies will provide easy access for ... ... (OTC,Bulletin Board: DSCI), a provider of advanced wound care products,announced today that ... has been cleared by the FDA for,over the counter (OTC) sales. This ...
... Executive,Director, Diana Fuentes-Michel today urged eligible nursing students ... college to immediately apply,for the 2007-08 academic year ... The deadline for applications is June 30, 2008., ... be aware of all available,resources to help them ...
Cached Medicine News:Health News:INSPIRIS Acquires Care Level Management 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 3Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 4Health News:National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment 2Health News:Golden Meditech Pioneers into China's Hospital Market 2Health News:Golden Meditech Pioneers into China's Hospital Market 3Health News:Golden Meditech Pioneers into China's Hospital Market 4Health News:Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter 2Health News:Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter 3Health News:Nursing Loan Forgiveness Programs -- More Applicants Needed by June 30, 2008 2
Volume: 5 ml; Volume Graduation: 1/10 ml...
... AlphaForce fills 25ml pipette in ... fatest setting. Rechargeable during use. ... all with variable speed including ... Autoclavable pipette holder. Low battery ...
Inquire...
A convenient, rotating standholds up to seven Gilson pipettes (any model) with exceptional stability. Protects your precious pipettes from possible damage or contamination....
Medicine Products: